ࡱ > r t k l m n o p q ' bjbjVV 4 < < ' f f f z H ; ; ; R ; ; ; ; I( ; 0 ; d d ; d ; h ; ; d f p : Supplemental figure 1 Supplemental data 1 A: Individual trend of relative change (% change ) in CCL2 over time compared to baseline in the bindarit group. B: Individual trend of relative change (% change ) in CCL2 over time compared to baseline in the placebo group. Supplemental figure 2 Supplemental data 2 A: Individual trend of relative change (% change ) in UAE over time compared to baseline in the bindarit group. B: Individual trend of relative change (% change ) in UAE over time compared to baseline in the placebo group. Supplemental figure 3 Supplemental data 3 A: Individual trend of proteinurua 24-h in the bindarit group. Six patients achieving remission (3 complete and 3 partial remission) in the bindarit group. Of these, two had a subsequent moderate relapse and one had a severe relapse. B: Individual trend of proteinurua 24-h in the placebo group. Six patients achieving remission (2 complete and 4 partial remission) in the placebo group. Of these, three had a subsequent moderate relapse and one had a severe relapse. F ' ) * + , - óubM8 (j3 hi hi UaJ mH nH tHu (j hi hi UaJ mH nH tHu $h/ hgy CJ OJ QJ aJ mH sH hgy CJ OJ QJ aJ mH sH hgy OJ QJ mH sH hgy h/ OJ QJ mH sH $hgy h/ CJ OJ QJ aJ mH sH h/ CJ OJ QJ aJ mH sH (jK+ hi hi UaJ mH nH tHu (j hi hi UaJ mH nH tHu $h/ h/ CJ OJ QJ aJ mH sH / ) + - A " 9 = Q < ' gdgy gd/ - ? @ X w z " 7 9 : ; < = : < ? d y & ' ݯΉvcvcvcvc $hveR hveR CJ OJ QJ aJ mH sH $hveR hgy CJ OJ QJ aJ mH sH $j h`I hi UmH nH tHu $j@ h`I hi UmH nH tHu $h/ hgy CJ OJ QJ aJ mH sH hgy OJ QJ mH sH hgy hgy OJ QJ mH sH hgy CJ OJ QJ aJ mH sH $hgy hgy CJ OJ QJ aJ mH sH 2 1h:p . A!n"n#$n% K+ D d K. l H A ? I m m a g i n e 2 " * vƋ g* D @=_* vƋ k W s -* x] xEg2If23]319 D -D9C4 ˊGVveO@DDWAK 1[N!ӰF}рppN-@ell_GmiEa[n&P_{&g p$lAfWԨk`Ke|֮pWv=jDz5cw﵍vтA7/mP}%{a}BQ7 wֱwl6Fl @ =[@+[?&@gޚջmyUxd˯-U2Y3m, ;9SԶ/.|a%SKeiOm~xp!J
X,Fl~B<V_.aޘtA엨oz9aNE)q8jl7uhO"P܆nʱ1 upԚKiK i+Q%g
:
uQrSӊfe[e^ |9F@: -08!Pc(|k?xNآ/Dus꼅ؕY